Co-Chaired by:
Max Herrmann, Managing Director, Stifel Financial Corp.
Rao Movva, Novartis Distinguished Scientist & Independent Pharma & Biotech Advisor
Panelists:
Dave Hallett, COO, Exscientia Ltd.
Edward Littler, Founder, Collaborative Community against Coronavirus (3C)
Gilead Raday, COO, RedHill Biopharma Ltd.
Richard Marsden, CEO, Synairgen Research Limited
